Technologies
PDF


WARF: P02000US

  • Assigned to WARF as biological material.

Collection of Drosophila Mutants with Neurodegenerative Effects


INVENTORS -

Barry Ganetzky, Michael Palladino, Robert Kreber

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in a collection of Drosophila mutants with obvious and distinct neurodegeneration.
OVERVIEWFew treatments for neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease, have been discovered.  In many cases, the molecular basis for neurodegeneration remains unknown.  Animal models might be useful for identifying new therapies, but few animal models for these diseases currently are available. 

Drosophila commonly are used as model organisms.  As many as 70 percent of human disease genes have homologues in Drosophila, making these organisms useful for identifying particular disease genes as well as subsequent assays for drug development.
THE INVENTIONUW-Madison researchers have compiled a collection of mutant Drosophila with obvious and distinct neurodegeneration.  Each of these mutants has a defect in a single gene.  They could be used to identify novel drug targets for neurodegenerative diseases.
APPLICATIONS
  • Screening programs aimed at identifying novel pharmaceutical agents and drug targets in an in vivo biological system
  • Functional genomic studies to identify novel genes involved in neural function and disease
  • An experimental model for human neurodegenerative disorders
KEY BENEFITS
  • Provides a good animal model for neurodegenerative diseases
Contact Information
For current licensing status, please contact Jennifer Gottwald at jennifer@warf.org or 608-960-9854.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.